Section ofDermatology 691
The finding in our patient suggests that the technique may be a highly sensitive index of incipient hepatic porphyria. Girl, aged 14 History: Since 6 months of age she has had recurrent ulcerative scarring suppurations of the skin with persistent anemia, polymorphonucleosis, hepatosplenomegaly, chest infections and some stunting of growth. The lesions begin as elevated haemorrhagic nodules, ulcerating and spreading rapidly to form raw necrotic areas exuding cloudy serum, healing after months and leaving extensive scars (Fig 1) .
A massive pyoderma of the left arm in 1965 was followed by a Staph. albus septicwmia and hemiplegia from a cerebral abscess or embolus. Some suppurations have followed trauma but the majority occur spontaneously. The gums show hyperplastic gingivitis with periodontal hyperplasia and loosening of the teeth. Childhood illness (chickenpox and measles) and antitetanus immunization have been tolerated normally. Family history: A brother died at 18 months of pneumonia, having had persistent pyoderma since birth. No history of undue susceptibility to infections was obtained in her living brother. Investigations: Hb 7.4 g/100 ml. WBC 18 900/mm3. Serum immunoglobulins: IgG 3840, IgM 400, IgA 62 mg/100 ml. Organisms: skin -Staph. aureus, Ps. pyocyanea, proteus; gumshimolytic and nonhimolytic streptococcus, N. catarrhalis. Biopsy: no granuloma; endarteritis and chronic inflammation. Treatment: There has been no dramatic response over 6-7 years to treatment with gammaglobulin (1965), local and systemic antibiotics, steroids (1966-70) as prednisone 10 mg or less daily, ACTH (1971) for weaning off steroids. Immunological tests: Bactericidal capacity of the polymorphonuclear leukocytes against Staph. aureus was measured by the method of Holmes et a!. (1966) . Bacteria and leukocytes were mixed in a 1:1 ratio and suspended in pooled normal serum to give a final concentration of 10%. The mixture was incubated for 20 min to allow phagocytosis to take place and then antibiotics were added to kill the remaining extracellular organisms. Samples were taken immediately, and at 140 min after lysis of the cells, to release ingested organisms; serial dilutions were made to estimate the number of organisms, by the pour plate method. The bactericidal capacity was calculated as a ratio of viable organisms at 140 and 20 min. Cells from mother, father, sibling and control were studied. In addition, the effect of the patient's serum on the same sample of cells from all these individuals was done in an identical manner. All tests were done in duplicate and repeated on different occasions. Lymphocyte transformation with phytoliemagglutinin (PHA) was measured. Antibody production following administration of tetanus toxoid on 3 occasions at monthly intervals was measured by Dr D G Barr at the Wellcome Research Laboratories. Total serum complement was estimated. Results: Definite impairment of intracellular digestion of the staphylococci by the patient's leukocytes in the presence of her own serum was found ( Table 1 ). The patient's serum had a similar but less marked effect on the mother's cells, but not on cells from the father, sibling or control. Normal leukocyte function was found in all these people when normal pooled serum was used. As can be seen from Table 1 the findings persisted despite withdrawal of steroid therapy. Phagocytosis was assessed by the number of organisms obtained in the 20 min sample irrespective of the serum used. Confirmation was obtained by staining smears of this sample with himatoxylin-eosin and counting the number of intracellular organisms per cell. Lymphocyte transformation with PHA was normal, and adequate antibody response to tetanus toxoid obtained (titre rose from 0.01 u/ml to 2 u/ml). Total serum complement was normal.
Comment
The chronicity and repetitiveness of the skin lesions, together with hepatosplenomegaly, anxmia, leukocytosis and raised gammaglobulin levels, were suggestive of an immunological disorder. Certain features were typical of chronic granulomatous disease (CGD), described by Berendes et al. (1957) and others (Bridges et al. 1959 , Thompson & Soothill 1970 , but a major difference was restriction of the suppurative lesions to the skin, without visceral abscesses, and granuloma formation. The defect in CGD is inability of the leukocyte to kill certain ingested organisms (Holmes et al. 1966 ). Investigation showed that our case did not have CGD but, when her cells were incubated with her serum, values similar to those obtained in the heterozygote of CGD were obtained. This patient also differs from the case reported by Miller et al.
(1968) of a child whose serum contained a factor affecting phagocytosis but not intracellular digestion, although clinical similarities are present. We were not able to test the effectiveness of fresh frozen plasma infusions as the parents were unwilling to embark on parenteral therapy, but we showed conclusively that correction of leukocyte function was possible in vitro.
We have been unable to determine the nature of this serum factor, but further studies are in progress to determine whether it is due to a circulating inhibitor or to lack of a substance necessary for normal leukocyte function. The findings in the mother and the likelihood that the sib who died was similarly affected raise the possibility of a genetic mode of inheritance.
Dr E J Moynahan: I have seen a 4-year-old girl, under the care of Dr Pamela Davis at the Hammersmith Hospital, who presented with extensive ulceration of the skin as in this patient. The salient laboratory findings were normal IgG, IgM, IgA, low haemoglobin and low serum iron, but high neutrophil count. Tests for chronic granulomatous disease were normal and, significantly, there was rapid improvement with blood transfusion. One is led to assume that the blood contained a missing serum factor which may be an opsonin as suggested by Miller et al. (1968) .
The following cases were also presented:
(1) Mast Cell Reticulosis (2) 
